Basics Travere Therapeutics, Inc. IPO Date: August 15, 2003 Sector: Healthcare Industry: Biotech Market Cap: $2.48B Activated in VL: True Average Daily Range Avg Daily Range: $0.46 | 2.56% Avg Daily Range (30 D): $0.64 | 2.51% Avg Daily Range (90 D): $0.49 | 2.45% Institutional Daily Volume Avg Daily Volume: .96M Avg Daily Volume (30 D): 1.69M Avg Daily Volume (90 D): 1.54M Trade Size Avg Trade Size (Sh.): 83 Avg Trade Size (Sh.) (30 D): 74 Avg Trade Size (Sh.) (90 D): 74 Institutional Trades Total Inst.Trades: 3,390 Avg Inst. Trade: $2.04M Avg Inst. Trade (30 D): $2.51M Avg Inst. Trade (90 D): $2.35M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.94M Avg Closing Trade (30 D): $5.49M Avg Closing Trade (90 D): $4.24M Avg Closing Volume: 172.99K     News Sep 29, 2025 @ 5:35 PM 10 Health Care Stocks With Whale Alerts In Today's... Source: Benzinga Staff Writer Mar 17, 2025 @ 11:01 AM Travere Therapeutics Submits sNDA to FDA for Appro... Source: N/A Feb 12, 2025 @ 10:30 PM Travere Therapeutics Reports Inducement Grants Und... Source: N/A Jan 6, 2025 @ 9:30 PM Travere Therapeutics to Present at the 43rd Annual... Source: N/A Nov 13, 2024 @ 10:00 PM Travere Therapeutics Reports Inducement Grants Und... Source: N/A Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.14 $-.47 $-.7 Diluted EPS $-.14 $-.47 $-.7 Revenue $ 114.45M $ 81.73M $ 62.9M Gross Profit $ 112.93M $ 77.05M $ 61.27M Net Income / Loss $ -12.76M $ -41.23M $ -54.81M Operating Income / Loss $ -12.65M $ -42.67M $ -56.15M Cost of Revenue $ 1.52M $ 4.68M $ 1.63M Net Cash Flow $ 13.26M $ 3.36M $ 4.12M PE Ratio     Splits Nov 08, 2011:   1:9